NUVB
Nuvation Bio Inc.
NYSE · USHealthcareBiotechnology
$6.26+7.93%
Price as of Jul 20, 2026
NUVB valuation
Nuvation Bio Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 211.50x
- P/S forward
- 22.02x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.82x
- Price / sales
- 15.24x
- Price / cash flow
- -17.34x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 11.58x
- EV / EBITDA
- -12.76x
- EV / EBIT
- -11.03x
- Market cap
- $2.2B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.